Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies

By Untch B.   Ahmad S.   Messmore H.L.   Schultz C.L.   Ma Q.   Hoppensteadt D.A.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 106, Iss. 2, 2002-04 ,pp. : 149-156

Elsevier

Access to resources Recommend Favorite

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

By Ahmad S.   Haas S.   Hoppensteadt D.A.   Lietz H.   Reid U.   Bender N.   Messmore H.L.   Misselwitz F.   Bacher P.   Gaikwad B.S.   Jeske W.P.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

Platelet Count, Anti-Heparin/Platelet Factor 4 Antibodies and Tissue Factor Pathway Inhibitor Plasma Antigen Level in Chronic Dialysis - A study of 44 cases

By Luzzatto G.   Bertoli M.   Cella G.   Fabris F.   Zaia B.   Girolami A.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 115-122

Elsevier

Access to resources Recommend Favorite

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia - The pathogenic role of IgG

By Untch B.   Ahmad S.   Jeske W.P.   Messmore H.L.   Hoppensteadt D.A.   Walenga J.M.   Lietz H.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

A megakaryocyte with no platelets: Anti-platelet antibodies, apoptosis, and platelet production

By Perdomo José   Yan Feng   Chong Beng H.  

Platelets, Vol. 24, Iss. 2, 2013-03 ,pp. : 98-106

Informa Healthcare

Access to resources Recommend Favorite